Prothena Corp Files 8-K: Other Events & Financials
Ticker: PRTA · Form: 8-K · Filed: May 23, 2025 · CIK: 1559053
| Field | Detail |
|---|---|
| Company | Prothena Corp Public Ltd Co (PRTA) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
Prothena filed an 8-K, but no juicy details yet.
AI Summary
On May 23, 2025, Prothena Corporation plc filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events or financial details disclosed in the provided text. The report confirms Prothena's incorporation in Ireland and provides its business and mailing addresses in Dublin.
Why It Matters
This 8-K filing indicates Prothena Corporation is making a regulatory submission, but the provided excerpt does not contain specific details about material events or financial performance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report with no disclosed material events or financial changes in the provided text.
Key Players & Entities
- Prothena Corporation plc (company) — Registrant
- Ireland (jurisdiction) — State of incorporation
- Dublin (location) — Business and mailing address city
FAQ
What is the primary purpose of this 8-K filing?
The filing is for "Other Events" and "Financial Statements and Exhibits" as of May 23, 2025.
When was this report filed?
The report was filed on May 23, 2025.
Where is Prothena Corporation plc incorporated?
Prothena Corporation plc is incorporated in Ireland.
What are Prothena's business and mailing addresses?
Both addresses are listed as 77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin 2, D02 T804, Ireland.
Does this filing disclose any specific material events or financial results?
Based on the provided text, no specific material events or financial results are disclosed; it only indicates the categories of information being reported.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding PROTHENA CORP PUBLIC LTD CO (PRTA).